天津发展(00882.HK):力生制药2024年归母净利润1.85亿元 拟10派3.5元

格隆汇
21 Mar

格隆汇3月21日丨天津发展(00882.HK)发布公告,力生制药(002393.SZ)2024年实现营业总收入13.36亿元(人民币,下同),同比增长15.88%;归属于母公司所有者的净利润1.85亿元,同比下降49%;基本每股收益0.72 元,拟向全体力生制药股东分派现金股息每10股派发现金红利人民币3.50元(含税)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10